This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics

Register by January 24 to save up to $1200

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
May 19-22, 2025
Manchester Grand Hyatt San DiegoSan Diego, CA

Stephen Dietrich
Associate Director, RNA Process Development at Sarepta Therapeutics
Speaker

Profile

Stephen Dietrich is an Associate Director in RNA Process Development at Sarepta Therapeutics. Stephen began his career in downstream process development in 2013. Early on, Stephen supported commercial scale-up and process characterization work for Sarepta’s commercial pipeline. In 2015 he transitioned into development of Sarepta’s next generation RNA pipeline developing new downstream unit operations and supporting early phase clinical tech transfer all the way through validation. Stephen currently leads a team of scientists and engineers focused on downstream development, scale-up, process characterization, and tech transfer for Sarepta’s RNA portfolio.

Agenda Sessions

  • Purification Scale up: A Case Study of Volume-Based Scale-Up Approaches in Oligonucleotide Chromatography

    3:00pm